Wanglong Qiu

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Gloria Huei-Ting Su · 5 shared papers, 2012–2021 · strength 0.45
   • Paper Dual Roles of the Activin Signaling Pathway in Pancreatic Cancer. DOI 10.3390/biomedicines9070821↗
   • Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9↗
   • Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007↗
2. Yan Han · 2 shared papers, 2019–2021 · strength 0.20
   • Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9↗
   • Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007↗
3. Yi Miao · 2 shared papers, 2019–2021 · strength 0.20
   • Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9↗
   • Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007↗
4. Haoqiang Ying · 1 shared paper, 2021 · strength 0.11
   • Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9↗
5. Ji Luo · 1 shared paper, 2021 · strength 0.11
   • Paper Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. DOI 10.1038/s41388-021-02040-9↗
6. Yunpeng Peng · 1 shared paper, 2019 · strength 0.09
   • Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007↗
7. Chunhua Xi · 1 shared paper, 2019 · strength 0.09
   • Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007↗
8. Jishu Wei · 1 shared paper, 2019 · strength 0.09
   • Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007↗
9. Min Tu · 1 shared paper, 2019 · strength 0.09
   • Paper HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. DOI 10.1016/j.canlet.2018.11.007↗
10. Richard D. Dinnen · 1 shared paper, 2013 · strength 0.04
    • Paper Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, d… DOI 10.1158/1535-7163.mct-13-0234↗
11. Robert Lance Fine · 1 shared paper, 2013 · strength 0.04
    • Paper Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, d… DOI 10.1158/1535-7163.mct-13-0234↗
12. Joseph DiNorcia · 1 shared paper, 2012 · strength 0.03
    • Paper RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model… DOI 10.1007/s11605-011-1754-9↗
13. Megan D. Winner · 1 shared paper, 2012 · strength 0.03
    • Paper RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model… DOI 10.1007/s11605-011-1754-9↗
14. John Allendorf · 1 shared paper, 2012 · strength 0.03
    • Paper RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model… DOI 10.1007/s11605-011-1754-9↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.